Groups urge Congress to boost funding for AMR, antibiotic development
In a letter sent yesterday to members of the House of Representatives and the Senate, organizations representing public health professionals, clinicians, scientists, patients, pharmaceutical and diagnostics companies, and animal agriculture experts called for increased funding in Fiscal Year 2022 for the Centers for Disease Control and Prevention’s efforts to address AMR, including $672 million for the Antibiotic Resistance Solutions Initiative, $100 million for the National Healthcare Safety Network, and $60 million for the Advanced Molecular Detection program.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.